目的 通过汇总分析本中心临床药师参与的肿瘤患者营养会诊,旨在为促进肿瘤患者的合理营养支持提供参考依据,以期提高临床药师的会诊能力及药学服务质量。方法 选取本中心2021年2月至2022年2月临床药师营养会诊的70例肿瘤患者,运用统计学方法分析比较患者营养风险筛查2002(nutrition risk screening,NRS 2002)、患者主观整体评估(patient-generated subjective global assessment,PG-SGA)评分、实验室检查、人体测量指标、24 h膳食回顾调查及个体化营养干预方案。结果 77.14%的会诊患者存在营养风险,以头颈部肿瘤、消化道肿瘤和肺癌居多,有无营养风险、不同PG-SGA分级(A、B、C)患者体质指数(body mass index,BMI)和24 h膳食量存在统计学差异,营养干预方案中饮食+口服营养补充(oral nutritional supplement,ONS)占比最高(35.71%),其次为饮食指导+营养教育(21.43%)与全肠外营养(total parenteral nutrition,TPN) (20.00%),个体化肠外营养支持中全合一营养液(all in one,AIO)占89.66%。结论 肿瘤患者营养风险和营养不良发生率较高,临床药师合理选择筛查工具,重视肿瘤患者营养状况的动态评估,为其提供个体化的营养治疗方案。
Abstract
OBJECTIVE To summarize and analyze nutritional consultations of cancer patients participated by clinical pharmacist, provide reference for promoting suitable nutritional support for cancer patients and improve the consultation ability of clinical pharmacist and the quality of pharmaceutical care. METHODS A total of 70 cancer patients underwent nutritional consultations with clinical pharmacist from February 2021 to February 2022 in the hospital were selected, NRS 2002, PG-SGA, laboratory examinations, anthropometric indices, 24 h dietary survey and individualized nutrition intervention programs were collected and statistic analyzed. RESULTS The 77.14% of the patients were at risk of malnutrition, most of which were head and neck neoplasms, gastrointestinal tumors, and lung cancer. There were significant differences in BMI and 24 h dietary intake among patients with or without nutritional risk and patients with different grades of PG-SGA (A, B, C). In the nutritional interventions, dietary+ONS accounted for the highest proportion (37.5%), followed by dietary guidance + nutrition education (21.43%) and TPN (20.00%), AIO accounted for 89.66% of individual parenteral nutrition support. CONCLUSION The prevalence of malnutrition is high in patients with cancer. Clinical pharmacist chooses screening methods properly, attach importance to the dynamic assessment of the nutritional status of cancer patients, and provide them with individualized nutritional treatment.
关键词
临床药师 /
肿瘤 /
营养风险筛查 /
患者主观整体评估 /
营养干预
{{custom_keyword}} /
Key words
clinical pharmacist /
tumor /
nutritional risk screening /
patient-generated subjective global assessment /
nutritional intervention
{{custom_keyword}} /
中图分类号：
R969.3
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2021, 71(3):209-249.
[2] ZHENG R S, SUN K X, ZHANG S W, et al. Report of cancer epidemiology in China, 2015[J]. Chin J Oncol (中华肿瘤杂志), 2019,41(1):19-28.
[3] SONG C H, WANG K H, GUO Z Q, et al. Investigation of nutritional status in Chinese patients with common cancer[J]. Sci Sin Vitae (中国科学 生命科学), 2020, 50(12):1437-1452.
[4] YANG Y X. China Food Composition Tables Standard Edition(中国食物成分表标准版) [M]. Vol Ⅰ. 6th ed. Beijing: Peking University Medical Press, 2018.
[5] YANG Y X. China Food Composition Tables Standard Edition (中国食物成分表标准版) [M]. Vol Ⅱ. 6th ed. Beijing: Peking University Medical Press, 2019.
[6] SONG C, CAO J, ZHANG F, et al. Nutritional risk assessment by scored patient-generated subjective global assessment associated with demographic characteristics in 23,904 common malignant tumors patients[J]. Nutr Cancer, 2019,71(1):50-60.
[7] LI X X, LIU F, GE Q G, et al. Guidelines on nutrition support therapy for acute respiratory disease: A systematic review[J].Chin Pharm J (中国药学杂志), 2020, 55(9):671-678.
[8] KONDRUP J, ALLISON S P, ELIA M, et al. ESPEN guidelines for nutrition screening 2002[J]. Clin Nutr, 2003,22(4):415-421.
[9] Chinese Medical Association. Clinical Practice Guidelines: Parenteral and Enteral Nutrition (临床诊疗指南: 肠外肠内营养学分册) [M].1st ed.Beijing:People′s Medical Publishing House,2008.
[10] MCCLAVE S A, TAYLOR B E, MARTINDALE R G, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically Ⅲ patient: society of critical care medicine(SCCM) and American society for parenteral and enteral nutrition (A.S.P.E.N.)[J]. J Parenter Enteral Nutr, 2016, 40(2):159-211.
[11] Chinese Society of Clinical Oncology Guidelines Working Group. Guidelines of Chinese Society Oncolocy (CSCO) Nutrition in Cancer Patients (中国临床肿瘤学会(CSCO)恶性肿瘤患者营养治疗指南) [M]. Beijing: People′s Medical Publishing House, 2019:79-83.
[12] ZHU M W, WEI J M, CHEN W, et al. Dynamic investigation of nutritional risk in patients with malignant tumor during hospitalization[J]. Natl Med J China (中华医学杂志), 2018, 98(14):1093-1098.
[13] MUSCARITOLI M, ARENDS J, BACHMANN P, et al. ESPEN practical guideline: Clinical Nutrition in cancer[J]. Clin Nutr, 2021, 40(5):2898-2913.
[14] TANG S H, WANG H, XIA C C, et al. Investigation on nutritional status of patients with gastrointestinal cancer undergoing chemotherapy[J].Parenter Enter Nutr(肠外与肠内营养), 2021,28(1):35-40.
[15] CAO D X, WU G H, ZHANG B, et al. Resting energy expenditure and body composition in patients with newly detected cancer[J]. Clin Nutr, 2010, 29(1):72-77.
[16] SUN H F, ZHANG L, WAN S L, et al. A comprehensive nutritional survey of oncology inpatients[J].Chin J Pract Surg (中国实用外科杂志), 2018, 38(6):654-658.
[17] LIU H L, ZHANG D, DENG X Z, et al. Significant of serum albumin, prealbumin, retinol binding protein and transferrin in postoperative parenteral nutrition support of gastric cancer[J]. China Med Her (中国医药导报), 2018,15(5):113-116.
[18] UESHIMA J, MOMOSAKI R, SHIMIZU A, et al. Nutritional Assessment in Adult Patients with Dysphagia: A Scoping Review[J]. Nutrients, 2021, 13(3):778. Doi: 10.3390/nu13030778.
[19] YU J M, YANG M, XU H X, et al. Association between serum C-reactive protein concentration and nutritional status of malignant tumor patients[J]. Nutr Cancer, 2019,71(2):240-245.
[20] SHI H P, XU H X, LI S Y, et al. Five-step treatment of malnutrition[J/OL]. Electron J Metab Nutr Cancer (肿瘤代谢与营养电子杂志), 2015,2(1):29-33.
[21] BARGETZI L, BRACK C, HERRMANN J, et al. Nutritional support during the hospital stay reduces mortality in patients with different types of cancers: secondary analysis of a prospective randomized trial[J]. Ann Oncol, 2021, 32(8):1025-1033.
[22] BANCOS I, ATKINSON E, ENG C, et al. Maternal and fetal outcomes in phaeochromocytoma and pregnancy: a multicentre retrospective cohort study and systematic review of literature[J]. Lancet Diabetes Endocrinol, 2021, 9(1):13-21.
[23] LIU H, HUANG Z G, WANG X H, et al. A multicenter cross-sectional survey on nutritional status andusing nutritional drugs for hospitalized patients with malignant digestive system tumors in Anhui area[J]. Chin J Hosp Pharm (中国医院药学杂志), 2021, 41(10):1044-1048.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
PDF(959 KB)
